6GH0

Two-quartet kit* G-quadruplex is formed via double-stranded pre-folded structure

6GH0 の概要

• エントリーDOI: 10.2210/pdb6gh0/pdb
• NMR情報: BMRB: 34269
• 分子名称: DNA (5'-D(*GP*GP*CP*GP*AP*GP*GP*AP*GP*GP*GP*GP*CP*GP*TP*GP*GP*CP*CP*GP*GP*C)-3') (1 entity in total)
• 機能のキーワード: g-quadruplex, two g-quartets, c-kit promoter, dna
• 由来する生物種: Homo sapiens
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 6940.44

構造登録者

Kotar, A.,Rigo, R.,Sissi, C.,Plavec, J. (登録日: 2018-05-04, 公開日: 2019-01-09, 最終更新日: 2024-05-15)

主引用文献

Kotar, A.,Rigo, R.,Sissi, C.,Plavec, J.
Two-quartet kit* G-quadruplex is formed via double-stranded pre-folded structure.
Nucleic Acids Res., 47:2641-2653, 2019

PubMed Abstract: In the promoter of c-KIT proto-oncogene, whose deregulation has been implicated in many cancers, three G-rich regions (kit1, kit* and kit2) are able to fold into G-quadruplexes. While kit1 and kit2 have been studied in depth, little information is available on kit* folding behavior despite its key role in regulation of c-KIT transcription. Notably, kit* contains consensus sites for SP1 and AP2 transcription factors. Herein, a set of complementary spectroscopic and biophysical methods reveals that kit*, d[GGCGAGGAGGGGCGTGGCCGGC], adopts a chair type antiparallel G-quadruplex with two G-quartets at physiological relevant concentrations of KCl. Heterogeneous ensemble of structures is observed in the presence of Na+ and NH4+ ions, which however stabilize pre-folded structure. In the presence of K+ ions stacking interactions of adenine and thymine residues on the top G-quartet contribute to structural stability together with a G10•C18 base pair and a fold-back motif of the five residues at the 3'-terminal under the bottom G-quartet. The 3'-tail enables formation of a bimolecular pre-folded structure that drives folding of kit* into a single G-quadruplex. Intriguingly, kinetics of kit* G-quadruplex formation matches timescale of transcriptional processes and might demonstrate interplay of kinetic and thermodynamic factors for understanding regulation of c-KIT proto-oncogene expression.

PubMed: 30590801
DOI: 10.1093/nar/gky1269

実験手法

SOLUTION NMR